Skip to content

Tenofovir / FTC 'non-inferior' to Combivir after one year, Gilead study shows (corrected)

US FDA approves coblistered triple combination for developing country use

Shire licenses SPD-754 to Avexa

Deoxyhypusine synthase: a new target for HIV therapy?

500mg Invirase tablet approved in the US

Tipranavir expanded access programme begins in US

Superiority of tipranavir / ritonavir confirmed in second salvage study

Truvada receives scientific approval in Europe

Once-daily abacavir receives approval in Europe